Limitations of the faecal occult blood test in screening for colorectal cancer

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 2, 1999, Pages 119-126

  Delco F ^a  

^a VA Medical Center   (United States)

Author keywords

Bayes' formula; Compliance; Cost effectiveness; Decision tree; Health economics; Markov process; Medical decision analysis; Test reliability

Indexed keywords

ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HUMAN; MODEL; OCCULT BLOOD; PATIENT COMPLIANCE;

COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; MARKOV CHAINS; MASS SCREENING; OCCULT BLOOD; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 0032924688     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Cancer Society. Cancer facts and figures, 1998. American Cancer Society Publication No. 5008.98. Atlanta, GA, 1998.
2. Otchy DP, Ransohoff DF, Wblff BG, Weaver A, Ilstrup D, Carlson H, et al. Metachronous colon cancer in persons who have had a large adenomatous polyp. Am J Gastroenterol 1996;91:448-54.
3. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-70.
4. Winawer SJ, Zauber AG, Ho MM, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
5. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1994, National Cancer Institute. NIH Publication No. 97-2789. Bethesda, MD, 1997.
6. Gregor DH. Diagnosis of large bowel cancer in the asymptomatic patient. J Am Med Ass 1967;201:943-5.
7. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
8. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. Ann Int Med 1993;118:1-6.
9. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 1996;348:1467-71.
10. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
11. Alquist DA. Occult blood screening: obstacles to effectiveness. Cancer 1992;70:1259-65.
12. Alquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. J Am Med Ass 1993;269:1262-7.
13. Lang C.A, Ransohoff DF. Fecal occult blood (FOB) screening for colorectal cancer: is mortalilty reduced by chance selection for screening colonoscopy? J Am Med Ass 1994:271:1011-3.
14. Ransohoff DF, Lang CA. Using colonoscopy to screen for colorectal cancer. Am J Gastroenterol 1994;89:1765-6.
15. Alquist D, McGill D, Wieand H, Moertel C, Loprinzi C, Devens M, et al. Fecal occult blood is an invalid screening marker for colorectal polyps. Gastroenterology 1991;100:A346.
16. Bat L, Pines A, Ron E, Niv Y, Arditi E, Shemesh E. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance. Am J Gastroenterol 1986;81:647-51.
17. Morris JB, Stellato TA, Guy BB, Gordon NH, Berger NA. A critical analysis of the largest reported mass fecal occult blood screening program in the United States. Am J Surg 1991;161:101-5.
18. Myers RE, Balshem AM, Wolf TA, Ross EA, Millner R. Adherence to continuous screening for colorectal neoplasia. Med Care 1993:31:508-19.
19. Lindholm E, Berglund B, Haglind E, Kewenter J. Factors associated with participation in screening for colorectal cancer with fecal occult blood testing. Scand J Gastroenterol 1995:30:171-6.
20. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994;29:468-73.
21. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Ann Intern Med 1990;112:328-33.
22. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989:24:599-606.
23. Rosner B. Fundamentals of biostatistics. Belmont, CA: Wadsworth Publishing Company; 1995.
24. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13:332-8.